captain_spork
Explorer
Could this be more about Belgium and the Netherlands specifically rather than the EU as a whole?skaylife said:
Customs are watching for it. Over the past 2 weeks, across various EU customs points, they seized medication worth a total of € 13.000.000. The bulk was medication, steroids, and peptides as well. They'll stay on the radar until FDA approval happens. And even with approval, the grey market never leaves the radar. Whether a package clears easily or gets stuck comes down to the sender's customs paperwork. That said, customs doesn't inspect every single package—only those that look suspicious or have questionable clearance. If your tracking shows a hold for customs clearance, that doesn't mean it's actually being inspected yet. The carrier is just holding it, waiting for an invoice, proof of payment, or some document to finish the clearance. If clearance isn't completed, they hand it over to customs. Packages sent via DHL that route through Germany are an entirely different situation, which I won't get into here. But right now, it's the safest option. Tracking stays quiet until a few days before delivery. That's not a problem—it's just how it works. Because DHL isn't the only one handling it. It only delivers within the EU.DrPEPr said:
Hey, welcome aboard!
Can't speak to EU-based warehouses — they tend to carry only a small range — but ordering straight from China has worked out fine for me (5 orders of my own plus 4 placed by friends nearby), and I haven't come across any problems either.
As far as I can tell, peptides aren't something customs is actively targeting.
Antwerp/Bruges and Rotterdam rank among Europe's biggest ports, and customs officials in those places are already doing heavy screening for narcotics and other banned items. Maybe peptides get stopped simply because they look like the kinds of compounds those officers are already watching for, and whether a package gets seized depends partly on which inspector opens it? Or has anyone seen proof that authorities are intentionally ramping up scrutiny of peptides or similar compounds, perhaps in expectation of upcoming regulatory shifts or approvals?
If the first explanation holds, might the higher seizure numbers just reflect that goods flow through major port nations such as the Netherlands and Belgium, rather than pointing to a wider EU-wide pattern? For instance, I'd guess the situation looks quite different in places like France or Poland, which don't play the same primary entry-point role.